Natraj Proteins returns to profit in FY26

1 min read     Updated on 24 May 2026, 04:55 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Natraj Proteins Limited reported a net profit of ₹113.51 lakh for FY26, reversing the previous year's loss of ₹146.27 lakh. Annual income from operations stood at ₹10112.13 lakh, while Q4 profit was ₹110.84 lakh on revenue of ₹1887.26 lakh.

powered bylight_fuzz_icon
41167514

*this image is generated using AI for illustrative purposes only.

Natraj Proteins Limited has announced its audited financial results for the year ended March 31, 2026, reporting a return to profitability. The company recorded a net profit of ₹113.51 lakh for the full fiscal year, a significant turnaround from the net loss of ₹146.27 lakh posted in the previous year ended March 31, 2025.

The board of directors approved the financial results during a meeting held on May 22, 2026. Total income from operations for FY26 stood at ₹10112.13 lakh, a decrease from the ₹11778.29 lakh reported in the prior year. Despite the lower revenue, improved cost management and operational efficiency contributed to the positive bottom line.

Financial Performance

The company's paid-up equity share capital remained constant at ₹374.70 lakh with a face value of ₹10 per share. Reserves, excluding revaluation reserve, increased to ₹2959.03 lakh as of March 31, 2026, compared to ₹2848.00 lakh in the previous year.

For the fourth quarter ended March 31, 2026, Natraj Proteins reported a net profit of ₹110.84 lakh. Total income for the quarter was ₹1887.26 lakh. The earnings per share (EPS) for the year improved to ₹3.03 from a negative ₹3.9 in the previous year.

Key Financial Metrics

Particulars Year Ended 31.03.2026 (Audited) Year Ended 31.03.2025 (Audited)
Total income from operations ₹10112.13 lakh ₹11778.29 lakh
Net Profit for the period ₹113.51 lakh ₹-146.27 lakh
Paid up Equity Share Capital ₹374.70 lakh ₹374.70 lakh
Reserves ₹2959.03 lakh ₹2848.00 lakh
Basic EPS ₹3.03 ₹(3.9)

The detailed financial results are available on the company's website and the BSE platform.

Historical Stock Returns for Natraj Proteins

1 Day5 Days1 Month6 Months1 Year5 Years
+6.83%+5.42%+6.29%+9.87%+0.12%-32.50%

What specific cost management strategies did Natraj Proteins implement in FY26, and are these measures sustainable enough to maintain profitability despite declining revenues in FY27?

Will Natraj Proteins announce a dividend for FY26 given the return to profitability, and how might this impact investor sentiment toward the stock?

What is driving the ~14% decline in revenue from operations, and does management have a concrete plan to reverse this downward trend in FY27?

Natraj Proteins Limited Dispatches KYC Compliance Letters to Physical Shareholders on May 9, 2026

2 min read     Updated on 09 May 2026, 05:33 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Natraj Proteins Limited notified BSE Limited on May 9, 2026, that its RTA, M/s Ankit Consultancy Pvt. Ltd., has dispatched KYC letters to physical securities holders requiring PAN, nomination, contact details, bank account details, and specimen signature. The action is in compliance with multiple SEBI circulars, including the latest SEBI Circular HO/38/13/(4)2026-MIRSD-POD/I/4298/2026 dated February 06, 2026. Shareholders are reminded that effective April 1, 2024, all dividend, interest, and redemption payments for physical folios must be processed through electronic mode only. The filing was made under Regulation 30 of SEBI (LODR) Regulations, 2015.

powered bylight_fuzz_icon
39873833

*this image is generated using AI for illustrative purposes only.

Natraj Proteins Limited, a solvent extraction plant and refinery based in Itarsi, Madhya Pradesh, has notified BSE Limited of the dispatch of KYC compliance letters to its shareholders holding physical securities. The communication, filed on May 9, 2026, was submitted in compliance with Regulation 30 read with Schedule III Part A Para A Clause No. 12 of SEBI (LODR) Regulations, 2015.

KYC Dispatch and Regulatory Background

The company's Registrar and Share Transfer Agent (RTA), M/s Ankit Consultancy Pvt. Ltd., has dispatched letters to physical securities holders requesting mandatory submission of key KYC details. The dispatch is pursuant to SEBI circular dated November 03, 2021, subsequently amended by circulars dated December 14, 2021, March 16, 2023, November 17, 2023, and May 7, 2024, as well as SEBI Circular No. SEBI Circular HO/38/13/(4)2026-MIRSD-POD/I/4298/2026 dated February 06, 2026.

The following details are required from shareholders holding physical securities:

  • PAN – Permanent Account Number
  • Choice of Nomination – via Form SH-13, or opt-out via Form ISR-3
  • Contact Details – Postal address with PIN and mobile number (via Form ISR-1)
  • Bank Account Details – Bank and branch name, account number, and IFS code (via Form ISR-1)
  • Specimen Signature – via Form ISR-2

Electronic Payment Mandate Effective April 1, 2024

Shareholders are advised that effective April 1, 2024, all payments including dividend, interest, or redemption in respect of physical folios shall be routed through electronic mode only. Folios that do not have PAN, KYC details, and Nomination updated will face restrictions on grievance lodging and service requests with the RTA until the required documents are furnished.

Submission Modes and RTA Contact Details

Shareholders may submit the required documents through any one of the following modes:

  • In Person Verification (IPV): The authorized person of the RTA verifies original documents and retains copies with IPV stamping
  • Hard copies: Self-attested and dated copies submitted directly
  • Electronic mode: Submission with e-sign as elaborated under the SEBI circular

The relevant forms and SEBI circulars are available on the company's website and the RTA's website. Key form links are summarised below:

Form: Purpose
ISR-1 Registration/updation of contact and bank details
ISR-2 Specimen signature registration
ISR-3 Declaration to opt out of nomination
SH-13 Registration of nomination
SH-14 Cancellation or variation of nomination
ISR-4 Issuance of duplicate securities / other requests
ISR-5 Transmission of securities

The RTA contact details are as follows:

Parameter: Details
Name: M/s Ankit Consultancy Pvt. Ltd.
Address: 60, Electronic Complex, Pardeshipura, Indore (M.P.) - 452 010
Telephone: 0731-4065799, 4065797, 4949444
Email: investor@ankitonline.com
Website: www.ankitonline.com

The filing was signed by Harshita Kirkire, Company Secretary and Compliance Officer (M. No.: A77514), on behalf of Natraj Proteins Limited.

Historical Stock Returns for Natraj Proteins

1 Day5 Days1 Month6 Months1 Year5 Years
+6.83%+5.42%+6.29%+9.87%+0.12%-32.50%

What percentage of Natraj Proteins' physical securities holders are expected to remain non-compliant after the KYC deadline, and how might this affect the company's dividend distribution process?

How could SEBI's ongoing push to dematerialize physical securities impact smaller companies like Natraj Proteins in terms of shareholder base consolidation and administrative costs?

Will persistent non-compliance by physical folio holders potentially lead to SEBI mandating a complete freeze on trading or transfer of such securities in future regulatory updates?

More News on Natraj Proteins

1 Year Returns:+0.12%